Refractory Progressive Multiple Sclerosis

CME

Video

Expert Insights on COVID-19 Prophylaxis in Patients With Multiple Sclerosis and Related Disorders

1.50 CME

1.50 NCPD

90 MINS

$0 FEE

Clinical Guidance

Multiple Sclerosis

Assessment and Treatment

Assessment of Multiple Sclerosis

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Multiple Sclerosis

Overview

Pathophysiology

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Multiple Sclerosis

Overview

Etiology and Risk Factors

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Multiple Sclerosis

Overview

Global Prevalence and Epidemiology

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News

January 23, 2024

1 min read

Save

FDA grants fast track designation for refractory progressive MS treatment

The FDA has granted fast track designation for an autologous, fully human CD19 chimeric antigen receptor T-cell product candidate to treat those with refractory progressive multiple sclerosis, according to the manufacturer.